Promoted Content
Promoted Content

Overview of Tamoxifen Citrate

Client Email Product
Tamoxifen Citrate
  • Synopsis

  • Chemistry

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
396

API Market Place

INTERMEDIATES
DOSSIERs
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

Dossiers Market Place

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

MEDIA

Blog

News

REFERENCE STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

0

SERVICES

0

  • WHO-GMP
Applications: Primellose® croscarmellose sodium is an effective super-disintegrant ,suitable for a variety of tablet and capsule formulations. It is effective when used intragranular and/or extragranular in granular formulations.
Ingredient(s): Croscarmellose Sodium
More Info on Category: Disintegrants & Superdisintegrants
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP
Technical Specifications: Not Available
  • WHO-GMP
Applications: Direct Compression, Dry granulation
Route of Administration (Grade): Solid Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Maize starch and Microcrystalline Cellulose
  • WHO-GMP
Applications: Orally Disintegrating Tablets/Sachets, Dispersible Tablets, Sachets, Chewable Tablets, Sublingual Tablets
Ingredient(s): Crospovidone
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to Japanese Pharmaceutical Excipients. All components meet USP-NF, JP, and EP. US DMF Type IV filed.
Technical Specifications: Not Available
  • WHO-GMP
Applications: Direct Compression, Dry Granulation
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Solid Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: For small dose API and large dose API with good compressibility.
  • WHO-GMP
Applications: Orally Disintegrating Tablets (ODTs) / Sachets, Dispersible Tablets / Sachets, Chewable Tablets, Sublingual Tablets.
Ingredient(s): Crospovidone
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to Japanese Pharmaceutical Excipients. All components meet USP-NF, JP, and EP.
Technical Specifications: Not Available
  • WHO-GMP
Applications: Direct Compression for pH sensitive APIs
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Solid Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Microcrystalline Cellulose, Light Magnesium Oxide, Sodium Starch Glycolate, Pregelatinized Starch, Maize Starch
  • WHO-GMP
Applications: Blend homogeneity even for low dose and micronized API’s, No need of other auxillary excipients
Route of Administration (Grade): Solid Oral
Pharmacopoeia Reference: USP-NF
Technical Specifications: Microcrystalline Cellulose and Colloidal Silicon Dioxide
  • WHO-GMP
Applications: Direct compression for moisture sensitive APIs
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Solid Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Microcrystalline Cellulose, Colloidal Silicon Dioxide, Povidone K30 and Crospovidone
  • WHO-GMP
Applications: Direct compression for moisture sensitive APIs
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Solid Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Microcrystalline Cellulose, Colloidal Silicon Dioxide, Povidone K30 and Sodium Starch Glycolate
left grey arrow
right gray arrow
  • TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
  • TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
  • SOLUTION;ORAL - EQ 20MG BASE/10ML